logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/nivolumabImmune-mediated colitis complicated by hypokalaemia and QT interval prolongation: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2020年 / 1790卷 / 1期
关键词:
D O I:
10.1007/s40278-020-74759-7
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:140 / 140
相关论文
共 50 条
  • [41] Ipilimumab/nivolumabImmune-mediated lichenoid drug eruption-sparing scar burns
    Reactions Weekly, 2024, 2001 (1) : 183 - 183
  • [42] MethadoneCorrected QT interval prolongation: case report
    Reactions Weekly, 2019, 1779 (1) : 156 - 156
  • [43] QuetiapineCorrected QT interval prolongation: case report
    Reactions Weekly, 2021, 1877 (1) : 344 - 344
  • [44] BuprenorphineBradycardia and QT interval prolongation: case report
    Reactions Weekly, 2021, 1842 (1) : 102 - 102
  • [45] BedaquilineCorrected QT interval prolongation: case report
    Reactions Weekly, 2021, 1858 (1) : 77 - 77
  • [46] MethadoneHypokalaemia and QT interval prolongation: case report
    Reactions Weekly, 2011, 1363 (1) : 28 - 28
  • [47] DelamanidWorsening of QT interval prolongation: case report
    Reactions Weekly, 2019, 1781 (1) : 135 - 135
  • [48] ZotepineFirst report of QT interval prolongation: case report
    Reactions Weekly, 2008, 1221 (1) : 31 - 31
  • [49] LorazepamFirst report of QT interval prolongation: case report
    Reactions Weekly, 2004, 1018 (1) : 11 - 11
  • [50] Ipilimumab/nivolumabImmune mediated type I diabetes: case report
    Reactions Weekly, 2018, 1728 (1) : 198 - 198
← 12345 →